Omar Abudayyeh works on novel genome editing and gene delivery tools and applies these tools to the study of aging. Abudayyeh and McGovern Fellow Jonathan Gootenberg continue to mine bacterial systems for new technologies to better enable gene therapy as well as apply these technologies towards studying mechanisms of aging.
Using next-generation single-cell sequencing and novel tools for perturbing cell states, Dr. Abudayyeh is determining, with unprecedented resolution, the cell types that arise in the aging brain and how mechanisms, such as senescence, drive detrimental processes in tissues.
The ultimate goal is to use this information to build a detailed roadmap of aging circuits and eventually reverse aging states for regenerating tissues like the brain.
In , Abudayyeh and Gootenberg founded Tome Biosciences, a programmable gene insertion company. Abudayyeh graduated from MIT in with a B. Goldwater Scholar. Omar Abudayyeh carried out an undergraduate research thesis with Sangeeta Bhatia on non-invasive cancer diagnostics using nanoparticle sensors, then conducted his Ph. He is one of the first members of the McGovern Institute Fellows program, which supports the transition to independent research for exceptional recent Ph.
Furthermore, she served as an analyst at the UAE Embassy in Washington, where her responsibilities spanned the trade and economy division, the media and culture department, and the consular affairs section. Born in Riyadh, she grew up in Washington, D.
